Ivermectin vs. Merck's New Antiviral, Molnupiravir

Based on Merck's data, a comparison between molnupiravir and ivermectin yields interesting results. Consider other nonprescription strategies for prevention and early treatment.

Oct 25, 2021

∙ Paid

Keep reading with a 7-day free trial

Subscribe to Dr. Mercola's Censored Library (Private Membership) to keep reading this post and get 7 days of free access to the full post archives.